As K-RITH takes root in Durban, we join a vibrant and dynamic research community that extends throughout South Africa and across the world.

K-RITH itself has grown out of strong cross-Atlantic collaborations that have connected clinical and research scientists in KwaZulu-Natal with their international colleagues. These collaborations—supported by the South African government; universities in South Africa, the United States, and Europe; the U.S. National Institutes of Health and Centers for Disease Control and Prevention; and philanthropic funding—have led to significant scientific and clinical discoveries that have advanced the treatment of HIV and tuberculosis. Once completed, the new K-RITH facility will be integrated with the existing Doris Duke Medical Research Institute, which houses the Centre for the Programme of AIDS Research In South Africa (CAPRISA) and the HIV Pathogenesis Programme (HPP).

K-RITH seeks to become a full participant in the South African research community and looks forward to fostering collaborations with the great research institutions there that are already making important contributions to the world’s understanding of tuberculosis and HIV.  These include the University of Cape Town, the University of the Witwatersrand in Johannesburg, the University of Pretoria, and Stellenbosch University, among many others.